Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Chi Lin

Showing results (51-60 of 152) with videos related to

Pageof 16
Sort By:
International Journal of Colorectal Disease|February 25, 2009
Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single instituteChun-Chi Lin, Jen-Kou Lin, Shih-Ching Chang, et al.
The International Journal of Biological Markers|April 6, 2013
Expression of ABCG2 associated with tumor response in metastatic colorectal cancer patients receiving first-line FOLFOX therapy--preliminary evidencePei-Ching Lin, Hung-Hsin Lin, Jen-Kou Lin, et al.
Scientific Reports|March 24, 2023
MiSelect R System: the validation of a new detection system of CTCs and their correlation with prognosis in non-metastatic CRC patientsChun-Chi Lin, Chih-Yung Yang, Tzu-Chao Hung, et al.
Cancer|April 21, 2015
Association of surgeon volume and hospital volume with the outcome of patients receiving definitive surgery for colorectal cancer: A nationwide population-based studyChia-Jen Liu, Yiing-Jenq Chou, Chung-Jen Teng, et al.
Asia-Pacific Journal of Clinical Oncology|March 4, 2016
Primary tumor location is an important predictive factor for wild-type KRAS metastatic colon cancer treated with cetuximab as front-line bio-therapyHsueh-Ju Lu, Jen-Kou Lin, Wei-Shone Chen, et al.
Journal of the Chinese Medical Association : JCMA|April 14, 2022
Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on low-grade appendiceal mucinous neoplasm: A single tertiary hospital experienceTai-Chuan Kuan, Wen-Yi Liang, Chun-Chi Lin, et al.
Annals of Coloproctology|January 26, 2023
Protective loop ileostomy or colostomy? A risk evaluation of all common complicationsYi-Wen Yang, Sheng-Chieh Huang, Hou-Hsuan Cheng, et al.
Molecular Oncology|September 26, 2024
CT45A1-mediated MLC2 (MYL9) phosphorylation promotes natural killer cell resistance and outer cell fate in a cell-in-cell structure, potentiating the progression of microsatellite instability-high colorectal cancerHao-Wei Teng, Hsiang-Yueh Huang, Chun-Chi Lin, et al.
Journal of Surgical Oncology|July 22, 2014
Genetic variations are associated with lymph node metastasis in colorectal cancer patientsYuan-Tzu Lan, Shung-Haur Yang, Jen-Kou Lin, et al.
Journal of Cancer|December 24, 2025
Interleukin-17 receptor A drives cancer stem-like properties in colorectal cancer through STAT3 activationJeng-Kai Jiang, Chi-Hung Lin, Chun-Chi Lin, et al.
Pageof 16

Showing results (51-60 of 152) with videos related to

Sort By:
Pageof 16
International Journal of Colorectal Disease|February 25, 2009
Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single instituteChun-Chi Lin, Jen-Kou Lin, Shih-Ching Chang, et al.
The International Journal of Biological Markers|April 6, 2013
Expression of ABCG2 associated with tumor response in metastatic colorectal cancer patients receiving first-line FOLFOX therapy--preliminary evidencePei-Ching Lin, Hung-Hsin Lin, Jen-Kou Lin, et al.
Scientific Reports|March 24, 2023
MiSelect R System: the validation of a new detection system of CTCs and their correlation with prognosis in non-metastatic CRC patientsChun-Chi Lin, Chih-Yung Yang, Tzu-Chao Hung, et al.
Cancer|April 21, 2015
Association of surgeon volume and hospital volume with the outcome of patients receiving definitive surgery for colorectal cancer: A nationwide population-based studyChia-Jen Liu, Yiing-Jenq Chou, Chung-Jen Teng, et al.
Asia-Pacific Journal of Clinical Oncology|March 4, 2016
Primary tumor location is an important predictive factor for wild-type KRAS metastatic colon cancer treated with cetuximab as front-line bio-therapyHsueh-Ju Lu, Jen-Kou Lin, Wei-Shone Chen, et al.
Journal of the Chinese Medical Association : JCMA|April 14, 2022
Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on low-grade appendiceal mucinous neoplasm: A single tertiary hospital experienceTai-Chuan Kuan, Wen-Yi Liang, Chun-Chi Lin, et al.
Annals of Coloproctology|January 26, 2023
Protective loop ileostomy or colostomy? A risk evaluation of all common complicationsYi-Wen Yang, Sheng-Chieh Huang, Hou-Hsuan Cheng, et al.
Molecular Oncology|September 26, 2024
CT45A1-mediated MLC2 (MYL9) phosphorylation promotes natural killer cell resistance and outer cell fate in a cell-in-cell structure, potentiating the progression of microsatellite instability-high colorectal cancerHao-Wei Teng, Hsiang-Yueh Huang, Chun-Chi Lin, et al.
Journal of Surgical Oncology|July 22, 2014
Genetic variations are associated with lymph node metastasis in colorectal cancer patientsYuan-Tzu Lan, Shung-Haur Yang, Jen-Kou Lin, et al.
Journal of Cancer|December 24, 2025
Interleukin-17 receptor A drives cancer stem-like properties in colorectal cancer through STAT3 activationJeng-Kai Jiang, Chi-Hung Lin, Chun-Chi Lin, et al.
Pageof 16